Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase <i>Escherichia coli</i> urinary tract infection treatment
- DOI
- 10.1093/ajhp/zxaa174
- Published
- 2020-08-25
- Container
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ajhp/zxaa174,
title = {Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase <i>Escherichia coli</i> urinary tract infection treatment},
author = {Kevin Deemer and Jonathan Grey and Christopher Fronczek and Kerry Marr},
year = {2020},
journal = {American Journal of Health-System Pharmacy},
doi = {10.1093/ajhp/zxaa174},
url = {https://doi.org/10.1093/ajhp/zxaa174}
}RIS
TY - JOUR TI - Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase <i>Escherichia coli</i> urinary tract infection treatment AU - Kevin Deemer AU - Jonathan Grey AU - Christopher Fronczek AU - Kerry Marr PY - 2020 JO - American Journal of Health-System Pharmacy DO - 10.1093/ajhp/zxaa174 UR - https://doi.org/10.1093/ajhp/zxaa174 ER -
APA
Deemer, K., Grey, J., Fronczek, C., & Marr, K. (2020). Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase <i>Escherichia coli</i> urinary tract infection treatment. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaa174
Source records
- crossref · retrieved 2026-09-25T11:43:50.307Z